michigan semaglutide ileus class action digestive blockage gastrointestinal obstruction Subocclusive following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) Lawsuit filed against semaglutide ileus legal team in

Patients should be counseled to report severe abdominal pain immediately Gallbladder disease : Increased risk of cholelithiasis and cholecystitis, likely related to rapid weight loss Hypoglycemia : Risk is low when used alone but increases when combined with insulin or sulfonylureas Thyroid C-cell tumors : Based on rodent studies, these agents carry a boxed warning and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Acute kidney injury : Can occur, particularly with dehydration from gastrointestinal side effects Diabetic retinopathy complications : Semaglutide may worsen diabetic retinopathy in patients with diabetes, particularly with rapid improvement in glucose control Severe gastrointestinal disease : Use with caution in patients with gastroparesis or severe gastrointestinal disease

The $50 copay does not count toward your Part D out-of-pocket maximum (set at $2,100 in 2026 and $2,400 in 2027)

Read about Ozempic and hypoglycemia here

How does the PlexusDx Precision Peptide Genetic Test help with semaglutide tolerance